COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 295: Articles 2941-2950  | Next

Enhanced Omicron subvariant cross-neutralization efficacy of a monovalent SARS-CoV-2 BA.4/5 mRNA vaccine encoding a noncleaved, nonfusogenic spike antigen
Seo, H. Y., Jung, H., Woo, H., Jung, H.-G., Bak, Y., Lee, S.-Y., Son, Y.-M., Yoon, G., Son, Y.-M., Hwang, S.-Y., Park, I., Shin, J.-S., Oh, J.-W.
10.1101/2023.09.10.557088 — Posted: 2023-09-11
Protocol for primary human lung organoid-derived air-liquid interface in vitro model to study response to SARS-CoV-2
Castaneda, D. C., Jangra, S., Yurieva, M., Martinek, J., Callender, M., Coxe, M., Choi, A., Diego, J. G.-B., Wu, T.-C., Marches, F., Chaussabel, D., Garcia-Sastre, A., Schotsaert, M., Williams, A., Palucka, K.
10.1101/2023.09.10.557067 — Posted: 2023-09-11
Bayesian phylogenetics on globally emerging SARS-CoV-2 variant BA.2.86 suggest global distribution and rapid evolution
Rothstein, A. P., Qiu, X., Robison, K., Collins, S., Muir, G., Lu, B., Plocik, A., Simen, B., Philipson, C.
10.1101/2023.09.08.556912 — Posted: 2023-09-11
The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2
Hilton, J., Nanao, Y., Flokstra, M., Askari, M., Smith, T. K., Di Falco, A., King, P. D., Wahl, P., Adamson, C. S.
10.1101/2023.09.08.556901 — Posted: 2023-09-11
Brain infection by wild-type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 variants of concern is a severe outcome in K18-hACE2 transgenic mice
Yicheng He, Y., Henley, J. E., Sell, P., Comai, L.
10.1101/2023.09.08.556906 — Posted: 2023-09-11
Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD Antibodies
Curtis, N. C., Shin, S., Hederman, A. P., Connor, R. I., Wieland-Alter, W. F., Ionov, S., Boylston, J., Rose, J., Sakharkar, M., Dorman, D. B., Dessaint, J. A., Gwilt, L. L., Crowley, A. R., Feldman, J., Hauser, B. M., Schmidt, A. G., Ashare, A., Walker, L. M., Wright, P. F., Ackerman, M. E., Lee, J.
10.1101/2023.09.08.556349 — Posted: 2023-09-11
A Network Analysis of Molecular Interactions to Study the Development of New-onset Diabetes and Hypertension after COVID-19 Infection Using Bioinformatics Tools.
de Oliveira Andrade, L. J., Matos de Oliveira, L. C., Matos de Oliveira, G. C., Matos de Oliveira, L.
10.1101/2023.09.10.23295323 — Posted: 2023-09-11
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Bolland, W., Michel, V., Planas, D., Hubert, M., Guivel-Benhassine, F., Porrot, F., Staropoli, I., N'Debi, M., Rodriguez, C., Fourati, S., Prot, M., Planchais, C., Hocqueloux, L., Simon-Loriere, E., Mouquet, H., Prazuck, T., Pawlotsky, J.-M., Bruel, T., Schwartz, O., Buchrieser, J.
10.1101/2023.09.06.556548 — Posted: 2023-09-11
Pre-dominance of dengue non-cross-reacting SARS-CoV-2 spike antibodies during the Omicron era and their role in the ADE-mediated surge of Dengue virus serotype 3
Sarker, S., Dutta, C., Mallick, A., Das, S., Das Chowdhury, C., De, A., Gorai, S., Biswas, S.
10.1101/2023.09.08.23295136 — Posted: 2023-09-10
Change in body weight of older adults before and during the COVID-19 pandemic: Longitudinal results from the Berlin Aging Study II
Vetter, V. M., Drewelies, J., Duezel, S., Homann, J., Meyer-Arndt, L., Braun, J., Pohrt, A., Kendel, F., Wagner, G. G., Thiel, A., Bertram, L., Regitz-Zagrosek, V., Gerstorf, D., Demuth, I.
10.1101/2023.09.08.23295246 — Posted: 2023-09-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).